Vineet Laboratories Limited — Capital/Financing Update 2025

Nov 27, 2025

==> picture [426 x 105] intentionally omitted <==

November 27, 2025

To BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001. BSE Scrip Code: 543298

To National Stock Exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051.

NSE Scrip Code: VINEETLAB

Dear Sir/Madam,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

With reference to the above stated subject, we hereby inform that the Board of Directors of the Company at its meeting held today i.e., on Thursday, November 27, 2025, approved the following:

1. Raise of funds by way of issue of equity shares of the Company of face value Rs.10/- (Rupee Ten Only) each for an aggregate amount not exceeding Rs.3,000 Lakhs (Rupees Three Thousand Lakhs) on Right issue basis, on such terms and conditions as may be decided by the Board of Directors / Rights Issue Committee to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently).

The issue is subject to the receipt of applicable regulatory, statutory approvals, in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, and the Companies Act, 2013 and the rules made thereunder, as amended from time to time.

1. Constitution of the Rights Issue Committee, consisting of Mr. Gaddam Venkata Ramana, Mr. Satyanarayana Raju Bhupathiraju, Mr. Premananda Reddy Vennapusa, Mr. Dilip Vishnu Acharekar empowering them to undertake all the necessary activities for the completion of the proposed Rights Issue.

The detailed terms of Right issue including the procedure for applying in the Right issue will be specified in the Letter of O�er, which will be sent - in due course - by the Company to all the eligible shareholders holding equity shares of the Company as on the record date.

==> picture [426 x 105] intentionally omitted <==

The details that need to be disclosed w.r.t the issuance of securities under Regulation 30 read with Schedule III of SEBI (LODR) Regulations read with SEBI Circular No. SEBI/ HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 are mentioned in Annexure 1.

The Board Meeting of the Company commenced at 11.30 AM and concluded at 12.30 P.M.

Kindly take this information on records.

Yours Sincerely,

For Vineet Laboratories Limited

GADDAM Digitally signed by GADDAM VENKATA VENKATA RAMANA Date: 2025.11.27 12:37:12 RAMANA +05'30'

Gaddam Venkata Ramana Managing Director DIN: 00031873

==> picture [426 x 105] intentionally omitted <==

Annexure-I

Disclosures as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sr.No.	Particulars	Details
1	Type of securities proposed to be issued (viz. equityshares,convertibles etc.);	Equity Shares
2	Type of issuance (further public o�ering, rights issue,depository receipts (ADR/GDR), qualifed institutionsplacement, preferential allotment etc.);	Rights Issue
3	Total number of securities proposed to be issued or thetotal amount for which the securities will be issued(approximately);	Upto Rs.3000 Lakhs

For Vineet Laboratories Limited

Digitally signed by GADDAM GADDAM VENKATA VENKATA RAMANA RAMANA Date: 2025.11.27 12:37:56 +05'30'

Gaddam Venkata Ramana Managing Director DIN: 00031873